Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells

Cancer Biology and Therapy

Volumn 10, Issue 4, 2010, Pages 368-375

  Sun, Jian Cong ^a,b   Pan, Ke ^a,b   Chen, Min Shan ^b   Wang, Qi Jing ^a,b   Wang, Hui ^a,b   Ma, Hai Qing ^a,b   Li, Yong Qiang ^a,b   Liang, Xiao Ting ^a,b   Li, Jian Jun ^a,b   Zhao, Jing Jing ^a,b   Chen, Yi Bing ^a,b   Pang, Xiong Hao ^b   Liu, Wang Li ^b   Cao, Yun ^b   Guan, Xin Yuan ^a   Lian, Qi Zhou ^c   Xia, Jian Chuan ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cancer stem cells; Dendritic cells; Hepatocellular carcinoma; Immunotherapy

Indexed keywords

CD133 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 7; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; RNA EXTRACTION;

ANIMALS; ANTIGENS, CD; CANCER VACCINES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DENDRITIC CELLS; GENE EXPRESSION; GLYCOPROTEINS; HUMANS; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-7; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; PEPTIDES; RNA; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77957120092     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.4.12440     Document Type: Article

References (18)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Clin 2005; 55:74-108.
2. Poon D, Anderson BO, Chen LT, Tanaka K, Lau WY, Van Cutsem E, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009; 10:1111-8.
3. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007; 132:2542-56. (Pubitemid 46890873)
4. + HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene 2008; 27:1749-58.
5. Lipscomb MF, Masten BJ. Dendritic cells: immune regulators in health and disease. Physiol Rev 2002; 82:97-130. (Pubitemid 34654216)
6. Ballestrero A, Boy D, Moran E, Cirmena G, Brossart P, Nencioni A. Immunotherapy with dendritic cells for cancer. Adv Drug Deliv Rev 2008; 60:173-83.
7. Butterfield LH, Ribas A, Dissette VB, Lee Y, Yang JQ, De la Rocha P, et al. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides. Clin Cancer Res 2006; 12:2817-25.
8. Palmer DH, Midgley RS, Mirza N, Torr EE, Ahmed F, Steele JC, et al. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma. Hepatology 2009; 49:124-32.
9. Pellegatta S, Poliani PL, Corno D, Menghi F, Ghielmetti F, Suarez-Merino B, et al. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas. Cancer Res 2006; 66:10247-52.
10. + cytolytic T cells. Cancer Res 2009; 69:8886-93.
11. + hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351:820-4.
12. Yin S, Li J, Hu C, Chen X, Yao M, Yan M, et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer 2007; 120:1444-50.
13. Song W, Li H, Tao K, Li R, Song Z, Zhao Q, et al. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma. Int J Clin Pract 2008; 62:1212-8.
14. + liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis. Hepatology 2009; 49:1277-86.
15. O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004; 104:2235-46. (Pubitemid 39331818)
16. Greten TF, Manns MP, Korangy F. Immunotherapy of hepatocellular carcinoma. J Hepatol 2006; 45:868-78.
17. + T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol 2008; 181:8576-84.
18. Carreno BM, Becker-Hapak M, Linette GP. CD40 regulates human dendritic cell-derived IL-7 production that, in turn, contributes to CD8(+) T-cell antigenspecific expansion. Immunol Cell Biol 2009; 87:167-77.